[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

COVID-19 Impact on Global Etoposide, Market Insights and Forecast to 2026

September 2020 | 115 pages | ID: C0B55D6289FEEN
QYResearch

US$ 3,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Etoposide market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Etoposide market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Etoposide market is segmented into
  • Etoposide for Injection
  • Etoposide for Oral Use
Segment by Application, the Etoposide market is segmented into
  • Small Cell Lung Cancer
  • Testicular Cancer
Regional and Country-level Analysis
The Etoposide market is analysed and market size information is provided by regions (countries).

The key regions covered in the Etoposide market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Etoposide Market Share Analysis
Etoposide market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Etoposide business, the date to enter into the Etoposide market, Etoposide product introduction, recent developments, etc.

The major vendors covered:
  • Shyndec Pharmaceutical
  • Qilu Antibiotics
  • Gansu Fuzheng
  • KPC Pharmaceuticals
  • China Resources Double Crane Pharmaceutical
  • Nippon Kayaku
  • Accord Healthcare
  • Teva Pharmaceutical
  • Mylan
1 STUDY COVERAGE

1.1 Etoposide Product Introduction
1.2 Market Segments
1.3 Key Etoposide Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
  1.4.1 Global Etoposide Market Size Growth Rate by Type
  1.4.2 Etoposide for Injection
  1.4.3 Etoposide for Oral Use
1.5 Market by Application
  1.5.1 Global Etoposide Market Size Growth Rate by Application
  1.5.2 Small Cell Lung Cancer
  1.5.3 Testicular Cancer
1.6 Coronavirus Disease 2019 (Covid-19): Etoposide Industry Impact
  1.6.1 How the Covid-19 is Affecting the Etoposide Industry
    1.6.1.1 Etoposide Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Etoposide Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Etoposide Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 EXECUTIVE SUMMARY

2.1 Global Etoposide Market Size Estimates and Forecasts
  2.1.1 Global Etoposide Revenue 2015-2026
  2.1.2 Global Etoposide Sales 2015-2026
2.2 Etoposide Market Size by Region: 2020 Versus 2026
  2.2.1 Global Etoposide Retrospective Market Scenario in Sales by Region: 2015-2020
  2.2.2 Global Etoposide Retrospective Market Scenario in Revenue by Region: 2015-2020

3 GLOBAL ETOPOSIDE COMPETITOR LANDSCAPE BY PLAYERS

3.1 Etoposide Sales by Manufacturers
  3.1.1 Etoposide Sales by Manufacturers (2015-2020)
  3.1.2 Etoposide Sales Market Share by Manufacturers (2015-2020)
3.2 Etoposide Revenue by Manufacturers
  3.2.1 Etoposide Revenue by Manufacturers (2015-2020)
  3.2.2 Etoposide Revenue Share by Manufacturers (2015-2020)
  3.2.3 Global Etoposide Market Concentration Ratio (CR5 and HHI) (2015-2020)
  3.2.4 Global Top 10 and Top 5 Companies by Etoposide Revenue in 2019
  3.2.5 Global Etoposide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Etoposide Price by Manufacturers
3.4 Etoposide Manufacturing Base Distribution, Product Types
  3.4.1 Etoposide Manufacturers Manufacturing Base Distribution, Headquarters
  3.4.2 Manufacturers Etoposide Product Type
  3.4.3 Date of International Manufacturers Enter into Etoposide Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Etoposide Market Size by Type (2015-2020)
  4.1.1 Global Etoposide Sales by Type (2015-2020)
  4.1.2 Global Etoposide Revenue by Type (2015-2020)
  4.1.3 Etoposide Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Etoposide Market Size Forecast by Type (2021-2026)
  4.2.1 Global Etoposide Sales Forecast by Type (2021-2026)
  4.2.2 Global Etoposide Revenue Forecast by Type (2021-2026)
  4.2.3 Etoposide Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Etoposide Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Etoposide Market Size by Application (2015-2020)
  5.1.1 Global Etoposide Sales by Application (2015-2020)
  5.1.2 Global Etoposide Revenue by Application (2015-2020)
  5.1.3 Etoposide Price by Application (2015-2020)
5.2 Etoposide Market Size Forecast by Application (2021-2026)
  5.2.1 Global Etoposide Sales Forecast by Application (2021-2026)
  5.2.2 Global Etoposide Revenue Forecast by Application (2021-2026)
  5.2.3 Global Etoposide Price Forecast by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Etoposide by Country
  6.1.1 North America Etoposide Sales by Country
  6.1.2 North America Etoposide Revenue by Country
  6.1.3 U.S.
  6.1.4 Canada
6.2 North America Etoposide Market Facts & Figures by Type
6.3 North America Etoposide Market Facts & Figures by Application

7 EUROPE

7.1 Europe Etoposide by Country
  7.1.1 Europe Etoposide Sales by Country
  7.1.2 Europe Etoposide Revenue by Country
  7.1.3 Germany
  7.1.4 France
  7.1.5 U.K.
  7.1.6 Italy
  7.1.7 Russia
7.2 Europe Etoposide Market Facts & Figures by Type
7.3 Europe Etoposide Market Facts & Figures by Application

8 ASIA PACIFIC

8.1 Asia Pacific Etoposide by Region
  8.1.1 Asia Pacific Etoposide Sales by Region
  8.1.2 Asia Pacific Etoposide Revenue by Region
  8.1.3 China
  8.1.4 Japan
  8.1.5 South Korea
  8.1.6 India
  8.1.7 Australia
  8.1.8 Taiwan
  8.1.9 Indonesia
  8.1.10 Thailand
  8.1.11 Malaysia
  8.1.12 Philippines
  8.1.13 Vietnam
8.2 Asia Pacific Etoposide Market Facts & Figures by Type
8.3 Asia Pacific Etoposide Market Facts & Figures by Application

9 LATIN AMERICA

9.1 Latin America Etoposide by Country
  9.1.1 Latin America Etoposide Sales by Country
  9.1.2 Latin America Etoposide Revenue by Country
  9.1.3 Mexico
  9.1.4 Brazil
  9.1.5 Argentina
9.2 Central & South America Etoposide Market Facts & Figures by Type
9.3 Central & South America Etoposide Market Facts & Figures by Application

10 MIDDLE EAST AND AFRICA

10.1 Middle East and Africa Etoposide by Country
  10.1.1 Middle East and Africa Etoposide Sales by Country
  10.1.2 Middle East and Africa Etoposide Revenue by Country
  10.1.3 Turkey
  10.1.4 Saudi Arabia
  10.1.5 U.A.E
10.2 Middle East and Africa Etoposide Market Facts & Figures by Type
10.3 Middle East and Africa Etoposide Market Facts & Figures by Application

11 COMPANY PROFILES

11.1 Shyndec Pharmaceutical
  11.1.1 Shyndec Pharmaceutical Corporation Information
  11.1.2 Shyndec Pharmaceutical Description, Business Overview and Total Revenue
  11.1.3 Shyndec Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
  11.1.4 Shyndec Pharmaceutical Etoposide Products Offered
  11.1.5 Shyndec Pharmaceutical Recent Development
11.2 Qilu Antibiotics
  11.2.1 Qilu Antibiotics Corporation Information
  11.2.2 Qilu Antibiotics Description, Business Overview and Total Revenue
  11.2.3 Qilu Antibiotics Sales, Revenue and Gross Margin (2015-2020)
  11.2.4 Qilu Antibiotics Etoposide Products Offered
  11.2.5 Qilu Antibiotics Recent Development
11.3 Gansu Fuzheng
  11.3.1 Gansu Fuzheng Corporation Information
  11.3.2 Gansu Fuzheng Description, Business Overview and Total Revenue
  11.3.3 Gansu Fuzheng Sales, Revenue and Gross Margin (2015-2020)
  11.3.4 Gansu Fuzheng Etoposide Products Offered
  11.3.5 Gansu Fuzheng Recent Development
11.4 KPC Pharmaceuticals
  11.4.1 KPC Pharmaceuticals Corporation Information
  11.4.2 KPC Pharmaceuticals Description, Business Overview and Total Revenue
  11.4.3 KPC Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
  11.4.4 KPC Pharmaceuticals Etoposide Products Offered
  11.4.5 KPC Pharmaceuticals Recent Development
11.5 China Resources Double Crane Pharmaceutical
  11.5.1 China Resources Double Crane Pharmaceutical Corporation Information
  11.5.2 China Resources Double Crane Pharmaceutical Description, Business Overview and Total Revenue
  11.5.3 China Resources Double Crane Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
  11.5.4 China Resources Double Crane Pharmaceutical Etoposide Products Offered
  11.5.5 China Resources Double Crane Pharmaceutical Recent Development
11.6 Nippon Kayaku
  11.6.1 Nippon Kayaku Corporation Information
  11.6.2 Nippon Kayaku Description, Business Overview and Total Revenue
  11.6.3 Nippon Kayaku Sales, Revenue and Gross Margin (2015-2020)
  11.6.4 Nippon Kayaku Etoposide Products Offered
  11.6.5 Nippon Kayaku Recent Development
11.7 Accord Healthcare
  11.7.1 Accord Healthcare Corporation Information
  11.7.2 Accord Healthcare Description, Business Overview and Total Revenue
  11.7.3 Accord Healthcare Sales, Revenue and Gross Margin (2015-2020)
  11.7.4 Accord Healthcare Etoposide Products Offered
  11.7.5 Accord Healthcare Recent Development
11.8 Teva Pharmaceutical
  11.8.1 Teva Pharmaceutical Corporation Information
  11.8.2 Teva Pharmaceutical Description, Business Overview and Total Revenue
  11.8.3 Teva Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
  11.8.4 Teva Pharmaceutical Etoposide Products Offered
  11.8.5 Teva Pharmaceutical Recent Development
11.9 Mylan
  11.9.1 Mylan Corporation Information
  11.9.2 Mylan Description, Business Overview and Total Revenue
  11.9.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
  11.9.4 Mylan Etoposide Products Offered
  11.9.5 Mylan Recent Development
11.1 Shyndec Pharmaceutical
  11.1.1 Shyndec Pharmaceutical Corporation Information
  11.1.2 Shyndec Pharmaceutical Description, Business Overview and Total Revenue
  11.1.3 Shyndec Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
  11.1.4 Shyndec Pharmaceutical Etoposide Products Offered
  11.1.5 Shyndec Pharmaceutical Recent Development

12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)

12.1 Etoposide Market Estimates and Projections by Region
  12.1.1 Global Etoposide Sales Forecast by Regions 2021-2026
  12.1.2 Global Etoposide Revenue Forecast by Regions 2021-2026
12.2 North America Etoposide Market Size Forecast (2021-2026)
  12.2.1 North America: Etoposide Sales Forecast (2021-2026)
  12.2.2 North America: Etoposide Revenue Forecast (2021-2026)
  12.2.3 North America: Etoposide Market Size Forecast by Country (2021-2026)
12.3 Europe Etoposide Market Size Forecast (2021-2026)
  12.3.1 Europe: Etoposide Sales Forecast (2021-2026)
  12.3.2 Europe: Etoposide Revenue Forecast (2021-2026)
  12.3.3 Europe: Etoposide Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Etoposide Market Size Forecast (2021-2026)
  12.4.1 Asia Pacific: Etoposide Sales Forecast (2021-2026)
  12.4.2 Asia Pacific: Etoposide Revenue Forecast (2021-2026)
  12.4.3 Asia Pacific: Etoposide Market Size Forecast by Region (2021-2026)
12.5 Latin America Etoposide Market Size Forecast (2021-2026)
  12.5.1 Latin America: Etoposide Sales Forecast (2021-2026)
  12.5.2 Latin America: Etoposide Revenue Forecast (2021-2026)
  12.5.3 Latin America: Etoposide Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Etoposide Market Size Forecast (2021-2026)
  12.6.1 Middle East and Africa: Etoposide Sales Forecast (2021-2026)
  12.6.2 Middle East and Africa: Etoposide Revenue Forecast (2021-2026)
  12.6.3 Middle East and Africa: Etoposide Market Size Forecast by Country (2021-2026)

13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS

13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Etoposide Players (Opinion Leaders)

14 VALUE CHAIN AND SALES CHANNELS ANALYSIS

14.1 Value Chain Analysis
14.2 Etoposide Customers
14.3 Sales Channels Analysis
  14.3.1 Sales Channels
  14.3.2 Distributors

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Research Methodology
  16.1.1 Methodology/Research Approach
  16.1.2 Data Source
16.2 Author Details
LIST OF TABLES

Table 1. Etoposide Market Segments
Table 2. Ranking of Global Top Etoposide Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Etoposide Market Size Growth Rate by Type 2020-2026 (Units) & (US$ Million)
Table 4. Major Manufacturers of Etoposide for Injection
Table 5. Major Manufacturers of Etoposide for Oral Use
Table 6. COVID-19 Impact Global Market: (Four Etoposide Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Etoposide Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Etoposide Players to Combat Covid-19 Impact
Table 11. Global Etoposide Market Size Growth Rate by Application 2020-2026 (Units)
Table 12. Global Etoposide Market Size by Region (Units) & (US$ Million): 2020 VS 2026
Table 13. Global Etoposide Sales by Regions 2015-2020 (Units)
Table 14. Global Etoposide Sales Market Share by Regions (2015-2020)
Table 15. Global Etoposide Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Etoposide Sales by Manufacturers (2015-2020) (Units)
Table 17. Global Etoposide Sales Share by Manufacturers (2015-2020)
Table 18. Global Etoposide Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Etoposide by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Etoposide as of 2019)
Table 20. Etoposide Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Etoposide Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Etoposide Price (2015-2020) (K USD/Unit)
Table 23. Etoposide Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Etoposide Product Type
Table 25. Date of International Manufacturers Enter into Etoposide Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Etoposide Sales by Type (2015-2020) (Units)
Table 28. Global Etoposide Sales Share by Type (2015-2020)
Table 29. Global Etoposide Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Etoposide Revenue Share by Type (2015-2020)
Table 31. Etoposide Average Selling Price (ASP) by Type 2015-2020 (K USD/Unit)
Table 32. Global Etoposide Sales by Application (2015-2020) (Units)
Table 33. Global Etoposide Sales Share by Application (2015-2020)
Table 34. North America Etoposide Sales by Country (2015-2020) (Units)
Table 35. North America Etoposide Sales Market Share by Country (2015-2020)
Table 36. North America Etoposide Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Etoposide Revenue Market Share by Country (2015-2020)
Table 38. North America Etoposide Sales by Type (2015-2020) (Units)
Table 39. North America Etoposide Sales Market Share by Type (2015-2020)
Table 40. North America Etoposide Sales by Application (2015-2020) (Units)
Table 41. North America Etoposide Sales Market Share by Application (2015-2020)
Table 42. Europe Etoposide Sales by Country (2015-2020) (Units)
Table 43. Europe Etoposide Sales Market Share by Country (2015-2020)
Table 44. Europe Etoposide Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Etoposide Revenue Market Share by Country (2015-2020)
Table 46. Europe Etoposide Sales by Type (2015-2020) (Units)
Table 47. Europe Etoposide Sales Market Share by Type (2015-2020)
Table 48. Europe Etoposide Sales by Application (2015-2020) (Units)
Table 49. Europe Etoposide Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Etoposide Sales by Region (2015-2020) (Units)
Table 51. Asia Pacific Etoposide Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Etoposide Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Etoposide Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Etoposide Sales by Type (2015-2020) (Units)
Table 55. Asia Pacific Etoposide Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Etoposide Sales by Application (2015-2020) (Units)
Table 57. Asia Pacific Etoposide Sales Market Share by Application (2015-2020)
Table 58. Latin America Etoposide Sales by Country (2015-2020) (Units)
Table 59. Latin America Etoposide Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Etoposide Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Etoposide Revenue Market Share by Country (2015-2020)
Table 62. Latin America Etoposide Sales by Type (2015-2020) (Units)
Table 63. Latin America Etoposide Sales Market Share by Type (2015-2020)
Table 64. Latin America Etoposide Sales by Application (2015-2020) (Units)
Table 65. Latin America Etoposide Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Etoposide Sales by Country (2015-2020) (Units)
Table 67. Middle East and Africa Etoposide Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Etoposide Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Etoposide Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Etoposide Sales by Type (2015-2020) (Units)
Table 71. Middle East and Africa Etoposide Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Etoposide Sales by Application (2015-2020) (Units)
Table 73. Middle East and Africa Etoposide Sales Market Share by Application (2015-2020)
Table 74. Shyndec Pharmaceutical Corporation Information
Table 75. Shyndec Pharmaceutical Description and Major Businesses
Table 76. Shyndec Pharmaceutical Etoposide Production (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2015-2020)
Table 77. Shyndec Pharmaceutical Product
Table 78. Shyndec Pharmaceutical Recent Development
Table 79. Qilu Antibiotics Corporation Information
Table 80. Qilu Antibiotics Description and Major Businesses
Table 81. Qilu Antibiotics Etoposide Production (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2015-2020)
Table 82. Qilu Antibiotics Product
Table 83. Qilu Antibiotics Recent Development
Table 84. Gansu Fuzheng Corporation Information
Table 85. Gansu Fuzheng Description and Major Businesses
Table 86. Gansu Fuzheng Etoposide Production (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2015-2020)
Table 87. Gansu Fuzheng Product
Table 88. Gansu Fuzheng Recent Development
Table 89. KPC Pharmaceuticals Corporation Information
Table 90. KPC Pharmaceuticals Description and Major Businesses
Table 91. KPC Pharmaceuticals Etoposide Production (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2015-2020)
Table 92. KPC Pharmaceuticals Product
Table 93. KPC Pharmaceuticals Recent Development
Table 94. China Resources Double Crane Pharmaceutical Corporation Information
Table 95. China Resources Double Crane Pharmaceutical Description and Major Businesses
Table 96. China Resources Double Crane Pharmaceutical Etoposide Production (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2015-2020)
Table 97. China Resources Double Crane Pharmaceutical Product
Table 98. China Resources Double Crane Pharmaceutical Recent Development
Table 99. Nippon Kayaku Corporation Information
Table 100. Nippon Kayaku Description and Major Businesses
Table 101. Nippon Kayaku Etoposide Production (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2015-2020)
Table 102. Nippon Kayaku Product
Table 103. Nippon Kayaku Recent Development
Table 104. Accord Healthcare Corporation Information
Table 105. Accord Healthcare Description and Major Businesses
Table 106. Accord Healthcare Etoposide Production (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2015-2020)
Table 107. Accord Healthcare Product
Table 108. Accord Healthcare Recent Development
Table 109. Teva Pharmaceutical Corporation Information
Table 110. Teva Pharmaceutical Description and Major Businesses
Table 111. Teva Pharmaceutical Etoposide Production (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2015-2020)
Table 112. Teva Pharmaceutical Product
Table 113. Teva Pharmaceutical Recent Development
Table 114. Mylan Corporation Information
Table 115. Mylan Description and Major Businesses
Table 116. Mylan Etoposide Production (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2015-2020)
Table 117. Mylan Product
Table 118. Mylan Recent Development
Table 119. Global Etoposide Sales Forecast by Regions (2021-2026) (Units)
Table 120. Global Etoposide Sales Market Share Forecast by Regions (2021-2026)
Table 121. Global Etoposide Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 122. Global Etoposide Revenue Market Share Forecast by Regions (2021-2026)
Table 123. North America: Etoposide Sales Forecast by Country (2021-2026) (Units)
Table 124. North America: Etoposide Revenue Forecast by Country (2021-2026) (US$ Million)
Table 125. Europe: Etoposide Sales Forecast by Country (2021-2026) (Units)
Table 126. Europe: Etoposide Revenue Forecast by Country (2021-2026) (US$ Million)
Table 127. Asia Pacific: Etoposide Sales Forecast by Region (2021-2026) (Units)
Table 128. Asia Pacific: Etoposide Revenue Forecast by Region (2021-2026) (US$ Million)
Table 129. Latin America: Etoposide Sales Forecast by Country (2021-2026) (Units)
Table 130. Latin America: Etoposide Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Middle East and Africa: Etoposide Sales Forecast by Country (2021-2026) (Units)
Table 132. Middle East and Africa: Etoposide Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 134. Key Challenges
Table 135. Market Risks
Table 136. Main Points Interviewed from Key Etoposide Players
Table 137. Etoposide Customers List
Table 138. Etoposide Distributors List
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources

LIST OF FIGURES

Figure 1. Etoposide Product Picture
Figure 2. Global Etoposide Sales Market Share by Type in 2020 & 2026
Figure 3. Etoposide for Injection Product Picture
Figure 4. Etoposide for Oral Use Product Picture
Figure 5. Global Etoposide Sales Market Share by Application in 2020 & 2026
Figure 6. Small Cell Lung Cancer
Figure 7. Testicular Cancer
Figure 8. Etoposide Report Years Considered
Figure 9. Global Etoposide Market Size 2015-2026 (US$ Million)
Figure 10. Global Etoposide Sales 2015-2026 (Units)
Figure 11. Global Etoposide Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Etoposide Sales Market Share by Region (2015-2020)
Figure 13. Global Etoposide Sales Market Share by Region in 2019
Figure 14. Global Etoposide Revenue Market Share by Region (2015-2020)
Figure 15. Global Etoposide Revenue Market Share by Region in 2019
Figure 16. Global Etoposide Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Etoposide Revenue in 2019
Figure 18. Etoposide Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Etoposide Sales Market Share by Type (2015-2020)
Figure 20. Global Etoposide Sales Market Share by Type in 2019
Figure 21. Global Etoposide Revenue Market Share by Type (2015-2020)
Figure 22. Global Etoposide Revenue Market Share by Type in 2019
Figure 23. Global Etoposide Market Share by Price Range (2015-2020)
Figure 24. Global Etoposide Sales Market Share by Application (2015-2020)
Figure 25. Global Etoposide Sales Market Share by Application in 2019
Figure 26. Global Etoposide Revenue Market Share by Application (2015-2020)
Figure 27. Global Etoposide Revenue Market Share by Application in 2019
Figure 28. North America Etoposide Sales Growth Rate 2015-2020 (Units)
Figure 29. North America Etoposide Revenue Growth Rate 2015-2020 (US$ Million)
Figure 30. North America Etoposide Sales Market Share by Country in 2019
Figure 31. North America Etoposide Revenue Market Share by Country in 2019
Figure 32. U.S. Etoposide Sales Growth Rate (2015-2020) (Units)
Figure 33. U.S. Etoposide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Canada Etoposide Sales Growth Rate (2015-2020) (Units)
Figure 35. Canada Etoposide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. North America Etoposide Market Share by Type in 2019
Figure 37. North America Etoposide Market Share by Application in 2019
Figure 38. Europe Etoposide Sales Growth Rate 2015-2020 (Units)
Figure 39. Europe Etoposide Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. Europe Etoposide Sales Market Share by Country in 2019
Figure 41. Europe Etoposide Revenue Market Share by Country in 2019
Figure 42. Germany Etoposide Sales Growth Rate (2015-2020) (Units)
Figure 43. Germany Etoposide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. France Etoposide Sales Growth Rate (2015-2020) (Units)
Figure 45. France Etoposide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. U.K. Etoposide Sales Growth Rate (2015-2020) (Units)
Figure 47. U.K. Etoposide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Italy Etoposide Sales Growth Rate (2015-2020) (Units)
Figure 49. Italy Etoposide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Russia Etoposide Sales Growth Rate (2015-2020) (Units)
Figure 51. Russia Etoposide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe Etoposide Market Share by Type in 2019
Figure 53. Europe Etoposide Market Share by Application in 2019
Figure 54. Asia Pacific Etoposide Sales Growth Rate 2015-2020 (Units)
Figure 55. Asia Pacific Etoposide Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Asia Pacific Etoposide Sales Market Share by Region in 2019
Figure 57. Asia Pacific Etoposide Revenue Market Share by Region in 2019
Figure 58. China Etoposide Sales Growth Rate (2015-2020) (Units)
Figure 59. China Etoposide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Japan Etoposide Sales Growth Rate (2015-2020) (Units)
Figure 61. Japan Etoposide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. South Korea Etoposide Sales Growth Rate (2015-2020) (Units)
Figure 63. South Korea Etoposide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. India Etoposide Sales Growth Rate (2015-2020) (Units)
Figure 65. India Etoposide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Australia Etoposide Sales Growth Rate (2015-2020) (Units)
Figure 67. Australia Etoposide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Taiwan Etoposide Sales Growth Rate (2015-2020) (Units)
Figure 69. Taiwan Etoposide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Indonesia Etoposide Sales Growth Rate (2015-2020) (Units)
Figure 71. Indonesia Etoposide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Thailand Etoposide Sales Growth Rate (2015-2020) (Units)
Figure 73. Thailand Etoposide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Malaysia Etoposide Sales Growth Rate (2015-2020) (Units)
Figure 75. Malaysia Etoposide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Philippines Etoposide Sales Growth Rate (2015-2020) (Units)
Figure 77. Philippines Etoposide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Vietnam Etoposide Sales Growth Rate (2015-2020) (Units)
Figure 79. Vietnam Etoposide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Asia Pacific Etoposide Market Share by Type in 2019
Figure 81. Asia Pacific Etoposide Market Share by Application in 2019
Figure 82. Latin America Etoposide Sales Growth Rate 2015-2020 (Units)
Figure 83. Latin America Etoposide Revenue Growth Rate 2015-2020 (US$ Million)
Figure 84. Latin America Etoposide Sales Market Share by Country in 2019
Figure 85. Latin America Etoposide Revenue Market Share by Country in 2019
Figure 86. Mexico Etoposide Sales Growth Rate (2015-2020) (Units)
Figure 87. Mexico Etoposide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Brazil Etoposide Sales Growth Rate (2015-2020) (Units)
Figure 89. Brazil Etoposide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Argentina Etoposide Sales Growth Rate (2015-2020) (Units)
Figure 91. Argentina Etoposide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America Etoposide Market Share by Type in 2019
Figure 93. Latin America Etoposide Market Share by Application in 2019
Figure 94. Middle East and Africa Etoposide Sales Growth Rate 2015-2020 (Units)
Figure 95. Middle East and Africa Etoposide Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Etoposide Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Etoposide Revenue Market Share by Country in 2019
Figure 98. Turkey Etoposide Sales Growth Rate (2015-2020) (Units)
Figure 99. Turkey Etoposide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia Etoposide Sales Growth Rate (2015-2020) (Units)
Figure 101. Saudi Arabia Etoposide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. U.A.E Etoposide Sales Growth Rate (2015-2020) (Units)
Figure 103. U.A.E Etoposide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Middle East and Africa Etoposide Market Share by Type in 2019
Figure 105. Middle East and Africa Etoposide Market Share by Application in 2019
Figure 106. Shyndec Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 107. Qilu Antibiotics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. Gansu Fuzheng Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. KPC Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. China Resources Double Crane Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Nippon Kayaku Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Accord Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Teva Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. North America Etoposide Sales Growth Rate Forecast (2021-2026) (Units)
Figure 116. North America Etoposide Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Europe Etoposide Sales Growth Rate Forecast (2021-2026) (Units)
Figure 118. Europe Etoposide Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Asia Pacific Etoposide Sales Growth Rate Forecast (2021-2026) (Units)
Figure 120. Asia Pacific Etoposide Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Latin America Etoposide Sales Growth Rate Forecast (2021-2026) (Units)
Figure 122. Latin America Etoposide Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Middle East and Africa Etoposide Sales Growth Rate Forecast (2021-2026) (Units)
Figure 124. Middle East and Africa Etoposide Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Porter's Five Forces Analysis
Figure 126. Channels of Distribution
Figure 127. Distributors Profiles
Figure 128. Bottom-up and Top-down Approaches for This Report
Figure 129. Data Triangulation
Figure 130. Key Executives Interviewed


More Publications